Business · 19/06/2007

FDA Releases Guidance on Pharmacogenetic and Genetic Tests for Heritable Markers

The Food and Drug Administration (FDA) has made available a guidance document that provides guidance on preparing and reviewing premarket approval applications and 510(k) submissions for pharmacogenetic and genetic tests, including those for multiple genetic markers simultaneously.